Statistics

Total Visits

Views
BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)89

Select a period of time:

Number of views in the range

Views
BEndamustine plus rituximab in first line systemic treatment for extranodal malt lymphoma: Final results of phase ii trial of the spanish lymphoma study group (geltamo)27

Views

Views
November 20252
December 20250
January 202612
February 20262
March 20263
April 20264
May 20264
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States14
Finland2
Angola1
Argentina1
Brazil1
Canada1
Colombia1
Germany1
Ecuador1
Spain1
 

Top cities views

Views
San Jose10
Helsinki2
Adapazarı1
Castrop-Rauxel1
Chiclayo1
Kankakee1
Lindsay1
Manta1
Mendoza1
Námestovo1